Doc Pharma S.A. is a Greek pharmaceutical company established in 2015. The company's core mission is to introduce innovative healthcare products and food supplements to the market, with a focus on promoting health and wellbeing. Doc Pharma is involved in the development, manufacturing, marketing, distribution, and export of generics and proprietary brands of food supplements. It also operates as a wholesaler for pharmaceutical products and cosmetics, distributing and exporting to various European markets with a global distribution capacity. Headquartered in Thessaloniki, Greece, Doc Pharma's manufacturing facility is located in Pallini, Athens. Both facilities are certified by the National Organisation for Medicines (E.O.F) for adhering to good manufacturing practice (GMP) and good distribution practice (GDP) guidelines. Moreover, the company holds an ISO 9001 certification, which further emphasizes its commitment to quality.
Doc Pharma's strategic positioning and its emphasis on innovation in healthcare products positions it well within the growing market for pharmaceuticals and supplements. With a strong focus on compliance and certifications, it has set a solid foundation for growth and expansion both within Europe and globally.
There is no investment information
No recent news or press coverage available for Doc Pharma S.A.